2026-2034年全球生物銀行市場規模、佔有率、趨勢和成長分析報告

預計生物銀行市場將從 2025 年的 43 億美元成長到 2034 年的 120 億美元，2026 年至 2034 年的複合年成長率為 12.07%。

由於科學研究和臨床應用對生物樣本和數據的需求不斷成長，生物銀行市場預計將迎來顯著成長。生物樣本庫在支持生物醫學研究中發揮著至關重要的作用，它們提供包括血液、組織和DNA樣本在內的各種生物材料。隨著全球對個人化醫療和基因組學的日益關注，對生物銀行服務的需求不斷上升，預計該市場將實現強勁成長。

此外，生物銀行技術的進步正在推動市場創新。自動化樣本處理、儲存解決方案和資料管理系統的發展正在提高生物樣本庫的效率和可靠性。這些創新不僅增強了樣本的完整性和可及性，還有助於與高通量定序和生物資訊學等先進調查方法的整合。隨著研究不斷探索生物銀行的新應用領域，在研究成果的提升和合作研究機會的推動下，市場預計將進一步擴張。

此外，生物銀行的格局正在發生變化，人們越來越關注倫理考量和監管合規性。隨著生物樣本庫在樣本收集和使用方面應對複雜的倫理框架和法規，對透明且合規的生物銀行方法的需求預計將會成長。這一趨勢在患者知情同意和資料隱私方面尤其重要，因為維護信任和透明度至關重要。隨著生物銀行市場的不斷發展，技術進步、倫理考量以及對合作的重視將共同塑造其未來的發展軌跡。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球生物銀行市場（按產品和服務分類）

• 市場分析、洞察與預測
• 設備（儲存設備、樣品分析設備、樣品處理設備、樣品運輸設備）
• 耗材（儲存耗材、分析耗材、處理耗材、採集耗材）
• 服務
• 軟體

5. 全球生物銀行市場（依樣本類型分類）

• 市場分析、洞察與預測
• 血液製品
• 人體組織
• 細胞株
• 核酸
• 生物體液
• 人類糞便

6. 全球生物銀行市場以儲存類型分類

• 市場分析、洞察與預測
• 手動儲存
• 自動儲存

7. 全球生物銀行市場（依所有權分類）

• 市場分析、洞察與預測
• 大學
• 國家和地區組織
• 非營利組織
• 私人組織

8. 全球生物銀行市場（按應用分類）

• 市場分析、洞察與預測
• 再生醫學
• 生命科學研究
• 臨床研究

9. 全球生物銀行市場（依最終用戶分類）

• 市場分析、洞察與預測
• 製藥和生物技術公司以及合約研究組織
• 學術研究機構
• 醫院

第10章：全球生物銀行市場（按地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Merck KGaA
  • Thermo Fisher ScientificInc
  • Becton, Dickinson And Company
  • PHC Holdings Corporation
  • AvantorInc
  • Greiner Holding AG
  • AzentaInc
  • Tecan Trading AG
  • Hamilton Company
  • CryoportInc
  • Micronic
  • AMSBIO
  • Bay Biosciences LLC
  • BioKryo
  • SPT Labtech

The Biobanking Market size is expected to reach USD 12.00 Billion in 2034 from USD 4.30 Billion (2025) growing at a CAGR of 12.07% during 2026-2034.

The biobanking market is poised for significant growth, driven by the increasing demand for biological samples and data for research and clinical applications. Biobanks play a crucial role in supporting biomedical research by providing access to a wide range of biological materials, including blood, tissue, and DNA samples. As the global focus on personalized medicine and genomics intensifies, the demand for biobanking services is expected to rise, positioning this market for robust expansion.

Moreover, advancements in biobanking technologies are driving innovation within the market. The development of automated sample processing, storage solutions, and data management systems is enhancing the efficiency and reliability of biobanks. These innovations not only improve sample integrity and accessibility but also facilitate the integration of biobanking with advanced research methodologies, such as high-throughput sequencing and bioinformatics. As research continues to explore new applications for biobanking, the market is likely to expand further, driven by the promise of improved research outcomes and collaboration.

Additionally, the growing emphasis on ethical considerations and regulatory compliance is shaping the biobanking landscape. As biobanks navigate complex ethical frameworks and regulations regarding sample collection and usage, the demand for transparent and compliant biobanking practices is likely to increase. This trend is particularly relevant in the context of patient consent and data privacy, where maintaining trust and transparency is essential. As the biobanking market continues to evolve, the combination of technological advancements, ethical considerations, and a focus on collaboration will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
• Consumables ( Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables)
• Services
• Software

By Sample Type

• Blood Products
• Human Tissues
• Cell Lines
• Nucleic Acids
• Biological Fluids
• Human Waste Products

By Storage Type

• Manual Storage
• Automated Storage

By Ownership

• Universities
• National/Regional Agencies
• Non-Profit Organizations
• Private Organizations

By Application

• Regenerative Medicine
• Life Science Research
• Clinical Research

By End user

• Pharmaceutical & Biotechnology Companies and CROs
• Academic & Research Institutes
• Hospitals

COMPANIES PROFILED

• Merck KGaA, Thermo Fisher Scientific, Inc, Becton, Dickinson and Company, PHC Holdings Corporation, Avantor, Inc, Greiner Holding AG, Azenta, Inc, Tecan Trading AG, Hamilton Company, Cryoport, Inc, Micronic, AMSBIO, Bay Biosciences LLC, BioKryo, SPT Labtech

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOBANKING MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Consumables ( Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOBANKING MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample Type
• 5.2. Blood Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Human Tissues Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cell Lines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Biological Fluids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Human Waste Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOBANKING MARKET: BY STORAGE TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Storage Type
• 6.2. Manual Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Automated Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOBANKING MARKET: BY OWNERSHIP 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Ownership
• 7.2. Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. National/Regional Agencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Non-Profit Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Private Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOBANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Life Science Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BIOBANKING MARKET: BY END USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End User
• 9.2. Pharmaceutical & Biotechnology Companies and CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL BIOBANKING MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product & Service
  • 10.2.2 By Sample Type
  • 10.2.3 By Storage Type
  • 10.2.4 By Ownership
  • 10.2.5 By Application
  • 10.2.6 By End User
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product & Service
  • 10.3.2 By Sample Type
  • 10.3.3 By Storage Type
  • 10.3.4 By Ownership
  • 10.3.5 By Application
  • 10.3.6 By End User
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product & Service
  • 10.4.2 By Sample Type
  • 10.4.3 By Storage Type
  • 10.4.4 By Ownership
  • 10.4.5 By Application
  • 10.4.6 By End User
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product & Service
  • 10.5.2 By Sample Type
  • 10.5.3 By Storage Type
  • 10.5.4 By Ownership
  • 10.5.5 By Application
  • 10.5.6 By End User
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product & Service
  • 10.6.2 By Sample Type
  • 10.6.3 By Storage Type
  • 10.6.4 By Ownership
  • 10.6.5 By Application
  • 10.6.6 By End User
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL BIOBANKING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Merck KGaA
  • 12.2.2 Thermo Fisher ScientificInc
  • 12.2.3 Becton, Dickinson And Company
  • 12.2.4 PHC Holdings Corporation
  • 12.2.5 AvantorInc
  • 12.2.6 Greiner Holding AG
  • 12.2.7 AzentaInc
  • 12.2.8 Tecan Trading AG
  • 12.2.9 Hamilton Company
  • 12.2.10 CryoportInc
  • 12.2.11 Micronic
  • 12.2.12 AMSBIO
  • 12.2.13 Bay Biosciences LLC
  • 12.2.14 BioKryo
  • 12.2.15 SPT Labtech